Business
Medgen signs deal with overstock.com as just the first of many amazing new developments slated for announcement in 2016
Medgen signs deal with overstock.com as just the first of many amazing new developments slated for announcement in 2016.
About this update from Medgen Inc
[{"type":"text","content":"HOLBROOK, N.Y., January 4, 2016 -- Medgen, Inc. (OTCPink: MDIN) today announced that the company has signed a supplier agreement with Internet giant, overstock.com, to distribute Medgen products to the millions of overstock.com customers, but this is just the beginning for the company heading into 2016. CEO, Matthew Briggs has been hard at work the past few months presenting and negotiating with retail stores of both the brick-and-mortar, and online varieties. Mr. Briggs explained, “There is no doubt that Medgen has everything going for it, including great products, dedicated customers, profitable manufacturing strategies, and powerful partners. The only thing really missing has been the distribution power the company needs to bring in serious cash flow. Until now we were still re-building a company, and I don’t think Medgen was ready to really go after the distribution it needed. Now it is. Naysayers may say that the distribution piece is the most difficult thing to get, but I say that is truly not so. Medgen has already had national distribution for at least one of its products. As recently as a few years age, Snorenz® was sold in Wal-Mart™, CVS™, Kmart™ and many major retail chains selling upwards of ten million bottles, and generating millions of dollars per year for the company. The only reason that stopped is that the company at the time decided to focus on different distribution strategies. The recent administration realizes past management’s error, and the rebuilding of the company’s all-natural product line has been underway for the past few years. I expect to have far more success in 2016 than the company had in the past. “Mr. Briggs’ optimism is well founded. Interest in the company’s newest products has been overwhelming and the company has been preparing for a major bump in manufacturing to fill the orders it expects in 2016. With all the pieces in place, the job of management this year will be two-fold. First, the company will re-open all distribution channels and add new ones to get national distribution of its entire line so that the company can earn the revenue it needs to become a global supplier of natural remedies. Second is to clean up its public equity, including getting audited financials, becoming fully reporting with the SEC, listing on a more reputable market, and utilizing its jump in revenue to ...